HomeXENE • NASDAQ
Xenon Pharmaceuticals Inc
add
$30.29
2.43%
After Hours:(0.00%)0.00
$30.29
Closed: May 16, 4:30:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.50M | — |
Operating expense | 80.24M | 442.48% |
Net income | -65.05M | -35.71% |
Net profit margin | -867.29 | — |
Earnings per share | -0.83 | -33.87% |
EBITDA | -72.10M | -23.37% |
Effective tax rate | -0.66% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.63M | -21.44% |
Total assets | 743.28M | -19.12% |
Total liabilities | 39.32M | 25.53% |
Total equity | 703.96M | — |
Shares outstanding | 78.69M | — |
Price to book | 3.30 | — |
Return on assets | -23.59% | — |
Return on capital | -24.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -65.05M | -35.71% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$29.57
Day range
$29.43 - $30.58
Year range
$26.74 - $46.00
Market cap
2.32B USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Headquarters
Website
Employees
322
